CANOPY GROWTH CORP (CGC) Stock Price, Forecast & Analysis
NASDAQ:CGC • CA1380357048
CGC Key Statistics, Chart & Performance
The current stock price of CGC is 1.19 USD. In the past month the price increased by 1.71%. In the past year, price decreased by -26.99%.
CGC Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to CGC. When comparing the yearly performance of all stocks, CGC is a bad performer in the overall market: 79.22% of all stocks are doing better.
CGC Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CGC. While CGC seems to be doing ok healthwise, there are quite some concerns on its profitability.
CGC Financial Highlights
Over the last trailing twelve months CGC reported a non-GAAP Earnings per Share(EPS) of -1.37. The EPS increased by 63.98% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -29.52% | ||
| ROE | -43.07% | ||
| Debt/Equity | 0.32 |
CGC Forecast & Estimates
13 analysts have analysed CGC and the average price target is 2.49 USD. This implies a price increase of 108.83% is expected in the next year compared to the current price of 1.19.
For the next year, analysts expect an EPS growth of 94.65% and a revenue growth 2.14% for CGC
CGC Ownership
CGC Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 30.08 | 967.332B | ||
| JNJ | JOHNSON & JOHNSON | 20.81 | 594.88B | ||
| MRK | MERCK & CO. INC. | 22.6 | 302.459B | ||
| PFE | PFIZER INC | 8.87 | 152.718B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.97 | 122.756B | ||
| ZTS | ZOETIS INC | 18.75 | 56.091B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.7 | 26.039B | ||
| VTRS | VIATRIS INC | 6.29 | 18.405B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 23.89 | 12.521B | ||
| AXSM | AXSOME THERAPEUTICS INC | 224.33 | 9.385B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About CGC
Company Profile
Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The company is headquartered in Smiths Falls, Ontario and currently employs 960 full-time employees. The company went IPO on 2010-06-04. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. The firm delivers innovative products from owned and licensed brands, including Tweed, 7ACRES, DOJA, Deep Space, and Claybourne, as well as category defining vaporization devices by Storz & Bickel. Its segments include Canada cannabis, and Storz & Bickel. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers. In addition, it serves medical cannabis patients globally with principal operations in Canada, Europe and Australia.
Company Info
CANOPY GROWTH CORP
1 Hershey Dr
Smiths Falls ONTARIO K7A0A8 CA
CEO: David Klein
Employees: 1029
Phone: 18555589333
CANOPY GROWTH CORP / CGC FAQ
Can you describe the business of CANOPY GROWTH CORP?
Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The company is headquartered in Smiths Falls, Ontario and currently employs 960 full-time employees. The company went IPO on 2010-06-04. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. The firm delivers innovative products from owned and licensed brands, including Tweed, 7ACRES, DOJA, Deep Space, and Claybourne, as well as category defining vaporization devices by Storz & Bickel. Its segments include Canada cannabis, and Storz & Bickel. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers. In addition, it serves medical cannabis patients globally with principal operations in Canada, Europe and Australia.
What is the stock price of CANOPY GROWTH CORP today?
The current stock price of CGC is 1.19 USD. The price increased by 1.71% in the last trading session.
Does CGC stock pay dividends?
CGC does not pay a dividend.
How is the ChartMill rating for CANOPY GROWTH CORP?
CGC has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Where is CANOPY GROWTH CORP (CGC) stock traded?
CGC stock is listed on the Nasdaq exchange.
How is the market expecting CGC stock to perform?
13 analysts have analysed CGC and the average price target is 2.49 USD. This implies a price increase of 108.83% is expected in the next year compared to the current price of 1.19.
Can you provide the upcoming earnings date for CANOPY GROWTH CORP?
CANOPY GROWTH CORP (CGC) will report earnings on 2026-05-28, after the market close.